-
ReLife study general questionnaire
Patients with localized stage I-III renal cell cancer (n=365) completed paper-and-pencil or web-based questionnaires at 3 months (n=368), 12 months (n=317), and 24 months... -
ReLife study clinical data
Data on tumour characteristics, treatment, complications, recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer... -
PRIDE Study questionnaire data
In this ongoing prospective cohort study, women complete web-based questionnaires at three time points in pregnancy (at enrollment [median gestational age 10 weeks], gestational... -
ReLife study tissue samples
Permission is available for collection of tumour blocks. -
Continuous Vital Parameters with Clinical Data of Patients Admitted to a...
Vital parameters measured with the VisiMobile (Sotera Wireless; San Diego, CA, USA) of inpatients at Radboudumc (Nijmegen, The Netherlands). The dataset records minute-by-minute... -
POM wearables
Wearable data of the Personalized Parkinson Project, including data obtained with a Verily watch. -
POM clinical data
Clinical data of the Personalized Parkinson Project, including motor scores, cognitive and neuropsychiatric assessments, autonomic symptoms, sleep and quality of life. -
UroLife study general questionnaire
Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3... -
ReLife study quality of life questionnaire
The EORTC QLQ-C30 was completed at 3 (n=365), 12 (n=317) and 24 months (n=279) after surgery. -
PRIDE Study blood samples
First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C. -
UroLife study blood samples
EDTA and heparin plasma samples were collected at 3 (n=1280) and 15 months (n=1122) after diagnosis. Heparin plasma samples have been analysed for carotenoids at 3 and 15 months... -
ReLife study abdominal CT scans
Abdominal CT scans are availabe for n=349 patients. -
UroLife study molecular subtypes
Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours. -
PRIDE Study obstetric records
Selected clinical data from obstetric records covering the pregnancy period and puerperium. Necessitates additional consent, provided by ~70% of participants -
PRIDE Study paternal questionnaire data
Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate. -
ReLife study body composition data
CT-based assessment of body composition is available for n=349 patients. -
PRISMA Questionnaire data
The extensive questionnaire covers a number of potential breast cancer risk predictors such as demographics, personal characteristics, reproductive characteristics, medication,... -
ReLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 3 (n=352), 12 (n=330) and 24 months (n=275) after surgery. -
PRIDE Study medication diaries
6-week medication diaries covering prescription and over-the counter use, administered in the second trimester of pregnancy. Available for 1516 PRIDE Study participants... -
ReLife study body composition data
CT-based assessment of body composition is available for n=349 patients.